or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    PPBT F Purple Biotech Ltd. 2.02
    GMAB F Genmab A/S 0.44
    EVAX F Evaxion Biotech A/S -5.00
    AGEN F Agenus Inc. 6.74
    CRIS F Curis, Inc. 9.73
    LYEL F Lyell Immunopharma, Inc. -9.05
    ADAP F Adaptimmune Therapeutics plc -3.64
    CCCC F C4 Therapeutics, Inc. -0.49
    BCAB F BioAtla, Inc. -4.73
    CGEM F Cullinan Management, Inc. -3.22
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Small Cell Lung Cancer Medicine Clinical Medicine Solid Tumors Biopharmaceutical Biotechnology Prostate Cancer Advanced Cancer Antibodies Breast Cancer Cancer Treatment Clinical Trial Immunology Immunotherapies Immunotherapy Infectious Diseases Metabolic Disorders Monoclonal Antibodies Multiple Myeloma

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 3.72
    FBT D First Trust Amex Biotech Index Fund 3.04
    CANC D Tema Oncology ETF 2.67
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.92
    WDNA D WisdomTree BioRevolution Fund 0.91
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare BBC to WDNA Compare CNCR to BBC Compare FBT to CANC

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Nov 20 CCCC C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
        Nov 19 AGEN Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 18 EVAX Evaxion Biotech files for offering of ADSs
        Nov 18 AGEN Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 16 ADAP Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 GMAB Genmab A/S (GMAB): Among 12 High Growth Large Cap Stocks to Buy Now
        Nov 15 AGEN Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround
        Nov 15 PPBT Purple Biotech GAAP EPS of -$0.39
        Nov 15 PPBT Purple Biotech Reports Third Quarter 2024 Financial Results
        Nov 15 ADAP Halozyme bids for Evotec; BeiGene gets a new name
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Small Cell Lung Cancer Medicine Clinical Medicine Solid Tumors Biopharmaceutical Biotechnology Prostate Cancer Advanced Cancer Antibodies Breast Cancer Cancer Treatment Clinical Trial Immunology Immunotherapies Immunotherapy Infectious Diseases Metabolic Disorders Monoclonal Antibodies Multiple Myeloma
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags